(Q42540843)

English

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia

scientific article published on May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1 reference

based on heuristic

inferred from title

author name string

Durrington PN

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Mackness MI

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Bhatnagar D

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Julier K

4

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Prais H

5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Arrol S

6

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Morgan J

7

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Wood GN

8

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

138

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

217-225

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

The effects of fibrates on lipoprotein and hemostatic coronary risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

How HDL protects against atheroma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Fibrinogen as a risk factor for stroke and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Fibrinolytic and thrombotic factors in atherosclerosis and IHD: the influence of triglyceride rich lipoproteins (TGRLP)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Double-blind placebo-controlled study of the effects of bezafibrate on blood lipids, lipoproteins, and fibrinogen in hyperlipidaemic type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

The fibrinolytic system and coagulation during bezafibrate treatment of hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Hypertriglyceridemia and regulation of fibrinolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Bezafibrate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Determination of HDL-cholesterol using 2,4,6-tribromo-3-hydroxybenzoic acid with a commercial CHOD-PAP reagent

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Determination of Lecithin: Cholesterol Acyltransfer in Human Blood Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

[Rapid physiological coagulation method in determination of fibrinogen]

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Effects of treatment of hypertriglyceridaemia with gemfibrozil on serum lipoproteins and the transfer of cholesteryl ester from high density lipoproteins to low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Mechanism of the gemfibrozil-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

'A'-esterases. Enzymes looking for a role?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900003-3

7 January 2021

Identifiers

10.1016/S0021-9150(98)00003-3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42540843&oldid=2078334502"